CCM: Concord Medical EV/EBITDA Multiple
The visualization of Concord Medical Services (CCM) market value demonstrates an EV/EBITDA ratio of 0.00. Concord Medical Services is expanding its network of oncology centers in China, integrating AI services and proprietary equipment to maintain customer retention. Revenue is generated from equipment sales and patient services within hospitals. Stable cash flows are secured by multi-year lease agreements, confirming the viability of this operating model.
Summary analytical data breakdowns for concordmedical.com (CCM)
- stock price and consensus target price:
- market capitalization information:
- issuer book value statistics:
- debt level and financial liquidity data:
Total Debt to Capital Concord Medical Services|CCM - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Concord Medical|CCM - Company Cumulative Debt|Debt to Book Capitalization Ratio Concord Medical Corp|CCM - Company Long-Term Loans and Borrowings|Company Short-Term Debts Concord Medical|Quick Liquidity Indicator concordmedical.com
- business earnings and investment ratios data:
CCM - Final Profit|Expected Profit Concord Medical Services|CCM - Price to Earnings Ratio|Forward P/E Multiple Concord Medical Services|CCM - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Concord Medical Corp|CCM - Operating profit before amortization|Net earnings per share (EPS TTM) Concord Medical|CCM - Net earnings per share for the last four quarters|Quarterly EPS earnings growth concordmedical.com|CCM - Net earnings per share growth this year|Earnings growth forecast for next year Concord Medical Services
Initial company analysis:CCM (Concord Medical Services Holdings Limited)
The EV/EBITDA metric, which compares enterprise value including net debt against operating profitability, is used to separate fundamental stability from market noise. By analyzing the EV/EBITDA multiple history of the business on the GURU.Markets platform, an investor assesses the ability of the Concord Medical Services (CCM) oncology center network to cover capital expenditures for expensive medical technology and power units using current cash flow.
Key competitors
HCA Healthcare - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio THC (Tenet Health)|Fresenius Medical Care - EV/EBITDA Multiple|solventum.com (SOLV) - Enterprise Value to EBITDA Ratio|Encompass Health Corporation (EHC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Universal Health Services, Inc. (UHS)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DaVita Inc|Enterprise Value to Operating Income Before Depreciation RDNT (RadNet Management)|EV/EBITDA Multiple OPCH|Enterprise Value to EBITDA Ratio surgerypartners.com SGRY|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Premier PINC|National Vision Holdings, Inc. (EYE) - Company Value to EBITDA|PGNY - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation ARDT (Ardent Health Corp)|SEM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ASTH|Enterprise Value to EBITDA Ratio MD|USPH: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pennant Group Inc (PNTG)|Enterprise Value to EBITDA Ratio Organogenesis Corp ORGO|EV/EBITDA Multiple NUTX (Nutex Health Inc.)|aunainvestors.com (AUNA) - Company Value to EBITDA|SBC Medical Group - EV/EBITDA Multiple|EOLS (Evolus Inc) - Enterprise Value to Operating Income Before Depreciation|CYH: EV/EBITDA Multiple|SKIN - Total Company Value to Operating Income Before Depreciation Ratio|MDWD (MediWound Ltd) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio biote.com (BTMD)|EV/EBITDA Multiple JYNT|EV/EBITDA Multiple DocGo, Inc. (DCGO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization P3 Health Partners PIII|gaintherapeutics.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|EUDA: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation BMGL (Basel Medical Group)|collplant.com (CLGN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CUPR - Total Company Value to Operating Income Before Depreciation Ratio|AMS (American Shared Hospital Services, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA MEDIROM Corp MRM|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalon GloboCare (ALBT)|DHAI (dih.com) - Business Value to Operating Income Before Depreciation|Carmell Therapeutics - Enterprise Value to EBITDA Ratio|NewGenIvf Group - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ATI Physical Therapy Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio CareMax, Inc CMAX|KDLY: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio modivcare.com|NVOS (Novo Integrated Sciences, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA SunLink Health Systems, Inc SSY|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IMAC Regeneration Centers (BACK)
